World Journal of Clinical Cases - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 28

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6410)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

265

WORD

HTML

2706

Figures (1-3)

533

Tables (1-1)

561

Sum=4120

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

915

Download

1375

Sum=2290

Oct 6, 2022 (publication date) through Oct 30, 2025

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Huang X, Hong Y, Xie SY, Liao HL, Huang HM, Liu JH, Long WJ. Malignant peritoneal mesothelioma with massive ascites as the first symptom: A case report. World J Clin Cases 2022; 10(28): 10317-10325 [PMID: 36246798 DOI: 10.12998/wjcc.v10.i28.10317]
URL:	https://www.wjgnet.com/2307-8960/full/v10/i28/10317.htm

Number	Citing Articles
1	Cisplatin/pemetrexed. Reactions Weekly 2023; 1944(1): 204 doi: 10.1007/s40278-023-33723-1
2	Chongxiang Xue, Zhe Dong, Kexin Tan, Xu Zhang, Yixuan Yu, Shuo Wang, Jiabin Zheng, Huijuan Cui. Pembrolizumab as an effective treatment for diffuse malignant peritoneal mesothelioma with long‑term survival: A case report and literature review. Oncology Letters 2025; 29(4) doi: 10.3892/ol.2025.14933
3	Xiao-Dong Peng, Zhen-Yu You, Lian-Xiang He, Qi Deng. Zimberelimab plus chemotherapy as the first-line treatment of malignant peritoneal mesothelioma: A case report and review of literature. World Journal of Clinical Cases 2023; 11(22): 5290 doi: 10.12998/wjcc.v11.i22.5290 Abstract() \| Core Tip() \| Full Article(HTML)() \| Times Cited (0) \| Total Visits (0) \| Open
4	Xiao-Dong Peng, Zhen-Yu You, Lian-Xiang He, Qi Deng. Zimberelimab plus chemotherapy as the first-line treatment of malignant peritoneal mesothelioma: A case report and review of literature. World Journal of Clinical Cases 2023; 11(22): 5296-5302 doi: 10.12998/wjcc.v11.i22.5296 Abstract(886) \| Core Tip(684) \| Full Article(HTML)(2173) \| Full Article with Cover (PDF)-10322K(183) \| Full Article (Word)-1084K(32) \| Audio-318K(4) \| Peer-Review Report-242K(110) \| Answering Reviewers-90K(96) \| Full Article (PDF)-9981K(204) \| Full Article (XML)-105K(105) \| Times Cited (2) \| Total Visits (8117) \| Open
5	Marie-Florence Reveneau, Julien Masliah-Planchon, Manuel Fernandez, Abdenour Ouikene, Bernard Dron, Innocenti Dadamessi, Charles Dayen, Lisa Golmard, Bruno Chauffert. Major response of a peritoneal mesothelioma to nivolumab and ipilimumab: a case report, molecular analysis and review of literature. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1410322